Prophylactic granulocyte transfusions during human bone marrow transplantation.

Area of Science:

• Hematology
• Infectious Disease
• Transplantation Medicine

Background:

• Bone marrow transplantation (BMT) patients are at high risk of infection due to profound neutropenia.
• Prophylactic strategies aim to mitigate infectious complications and improve outcomes.

Purpose of the Study:

• To evaluate the efficacy and safety of prophylactic granulocyte transfusions combined with oral nonabsorbable antibiotics versus oral nonabsorbable antibiotics alone in BMT recipients.
• To assess the impact on septicemia, other infections, and survival.

Main Methods:

• A randomized controlled trial involving 38 uninfected BMT patients.
• Patients received either prophylactic granulocyte transfusions plus oral antibiotics or oral antibiotics alone when neutrophil counts fell below 0.5 x 10(9)/liter.

Main Results:

• No significant difference in septicemia rates between groups (p=0.23), though all cases were in the antibiotic-alone group.
• No difference in other infections or survival.
• Significantly higher incidence of cytomegalovirus (CMV) infections in the granulocyte transfusion group (p=0.043).

Conclusions:

• Prophylactic granulocyte transfusions may prevent septicemia but are associated with increased CMV infections.
• Oral nonabsorbable antibiotics alone demonstrate comparable efficacy in preventing serious infections and survival in BMT recipients.
• The findings suggest oral antibiotics alone may be a sufficient prophylactic strategy.